AD

Ambika Devi

Active Director Director DIN 09453763
DIN 09453763 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Ambika Devi

Data last updated:

Ambika Devi is a Director at Medsys Pharma Private Limited (since 2021). The company operates in Chemicals. Medsys Pharma Private Limited reported revenue of ₹2,000 (FY 2024).

DIN 09453763
Primary Designation Director
Industry Chemicals
First Appointment 31 Dec 2021
Oldest Company Age 4 yrs
Largest company Medsys Pharma Private Limited · ₹2,000 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medsys Pharma Private Limited U24100UP2021PTC157572
Director31 Dec 20212021₹2,000 (FY 2024)Active

Board colleagues of Ambika Devi

NameDINCompanyDesignation
Pankaj Kumar09453764Medsys Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medsys Pharma Private Limited
Premium access

Shareholding and investment profile for Ambika Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ambika Devi

Ambika Devi currently holds 1 directorship: Medsys Pharma Private Limited (Director, since 31 Dec 2021, revenue ₹2,000 (FY 2024)).

Ambika Devi was first appointed on 31 Dec 2021 as Director at Medsys Pharma Private Limited.

The current boards of Ambika Devi's companies include Pankaj Kumar (Medsys Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available